Progression of insulin resistance: A link between risk factors and the incidence of diabetes

Published:February 05, 2020DOI:https://doi.org/10.1016/j.diabres.2020.108050

      Abstract

      Aims

      Insulin resistance (IR) changes over time during the development of type 2 diabetes. Some reports showed that obesity was associated with progression of IR. However, no study has explored if change of IR predicts incident diabetes, and no study has investigated other factors associated with the change.

      Methods

      In this study, 1184 subjects without diabetes at baseline were enrolled in 2006–2016 with a median follow-up period of 4.5 years. Diabetes was diagnosed by oral glucose tolerance test and hemoglobin A1c, or if anti-diabetic agents were used. HOMA2-IR and ISI0,120 were used to estimate IR.

      Results

      The annual changes of HOMA2-IR(ΔHOMA2-IR/year) and ISI0,120(ΔISI0,120/year) were associated with BMI, waist circumference(WC), glucose, HbA1c, triglyceride and HDL-cholesterol. Subjects with pre-diabetes or metabolic syndrome were associated with a more rapid increase of IR. ΔHOMA2-IR/year and ΔISI0,120/year were correlated with annual changes of BMI and WC. The hazard ratios for ΔHOMA2-IR/year and ΔISI0,120/year to predict incident diabetes were 1.39 (95% CI 1.22–1.59, p < 0.001) and 0.13 (95% CI 0.09–0.19, p < 0.001) in adjusted models, respectively.

      Conclusions

      Change of IR can be used as a surrogate marker of incident diabetes. The progression of IR is an important pathophysiologic link between risk factors and the incidence of diabetes.

      Keywords

      To read this article in full you will need to make a payment

      References

        • Moller D.E.
        • Flier J.S.
        Insulin resistance–mechanisms, syndromes, and implications.
        N Engl J Med. 1991; 325: 938-948
        • Ye J.
        Mechanisms of insulin resistance in obesity.
        Front Med. 2013; 7: 14-24
        • Ferrannini E.
        • Natali A.
        • Capaldo B.
        • Lehtovirta M.
        • Jacob S.
        • Yki-Jarvinen H.
        Insulin resistance, hyperinsulinemia, and blood pressure: role of age and obesity. European Group for the Study of Insulin Resistance (EGIR).
        Hypertension. 1997; 30: 1144-1149
        • Lakka H.M.
        • Salonen J.T.
        • Tuomilehto J.
        • Kaplan G.A.
        • Lakka T.A.
        Obesity and weight gain are associated with increased incidence of hyperinsulinemia in non-diabetic men.
        Horm Metab Res. 2002; 34: 492-498
        • Chang Y.
        • Sung E.
        • Yun K.E.
        • Jung H.S.
        • Kim C.W.
        • Kwon M.J.
        • et al.
        Weight change as a predictor of incidence and remission of insulin resistance.
        PLoS ONE. 2013; 8e63690
        • Peplies J.
        • Bornhorst C.
        • Gunther K.
        • Fraterman A.
        • Russo P.
        • Veidebaum T.
        • et al.
        Longitudinal associations of lifestyle factors and weight status with insulin resistance (HOMA-IR) in preadolescent children: the large prospective cohort study IDEFICS.
        Int J Behav Nutr Phys Act. 2016; 13: 97
        • Carnethon M.R.
        • Fortmann S.P.
        • Palaniappan L.
        • Duncan B.B.
        • Schmidt M.I.
        • Chambless L.E.
        Risk factors for progression to incident hyperinsulinemia: the Atherosclerosis Risk in Communities Study, 1987–1998.
        Am J Epidemiol. 2003; 158: 1058-1067
        • Vistisen D.
        • Witte D.R.
        • Tabak A.G.
        • Herder C.
        • Brunner E.J.
        • Kivimaki M.
        • et al.
        Patterns of obesity development before the diagnosis of type 2 diabetes: the Whitehall II cohort study.
        PLoS Med. 2014; 11: e1001602
        • Kuwahara K.
        • Honda T.
        • Nakagawa T.
        • Yamamoto S.
        • Hayashi T.
        • Mizoue T.
        Body mass index trajectory patterns and changes in visceral fat and glucose metabolism before the onset of type 2 diabetes.
        Sci Rep. 2017; 7: 43521
        • Li H.Y.
        • Wei J.N.
        • Lin M.S.
        • Smith D.J.
        • Vainio J.
        • Lin C.H.
        • et al.
        Serum vascular adhesion protein-1 is increased in acute and chronic hyperglycemia Clinica chimica acta.
        Int J Clin Chem. 2009; 404: 149-153
        • Ma W.Y.
        • Yang C.Y.
        • Shih S.R.
        • Hsieh H.J.
        • Hung C.S.
        • Chiu F.C.
        • et al.
        Measurement of Waist Circumference: midabdominal or iliac crest?.
        Diabetes Care. 2013; 36: 1660-1666
      1. American Diabetes A. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2018. Diabetes care. 2018;41:S13-S27.

      2. National Cholesterol Education Program Expert Panel on Detection E, Treatment of High Blood Cholesterol in A. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002, 106, 3143-421

        • Hill N.R.
        • Levy J.C.
        • Matthews D.R.
        Expansion of the homeostasis model assessment of beta-cell function and insulin resistance to enable clinical trial outcome modeling through the interactive adjustment of physiology and treatment effects: iHOMA2.
        Diabetes Care. 2013; 36: 2324-2330
        • Gutt M.
        • Davis C.L.
        • Spitzer S.B.
        • Llabre M.M.
        • Kumar M.
        • Czarnecki E.M.
        • et al.
        Validation of the insulin sensitivity index (ISI(0,120)): comparison with other measures.
        Diabetes Res Clin Pract. 2000; 47: 177-184
        • Riserus U.
        • Arnlov J.
        • Berglund L.
        Long-term predictors of insulin resistance: role of lifestyle and metabolic factors in middle-aged men.
        Diabetes Care. 2007; 30: 2928-2933
        • Wannamethee S.G.
        • Shaper A.G.
        Weight change and duration of overweight and obesity in the incidence of type 2 diabetes.
        Diabet Care. 1999; 22: 1266-1272
        • Biggs M.L.
        • Mukamal K.J.
        • Luchsinger J.A.
        • Ix J.H.
        • Carnethon M.R.
        • Newman A.B.
        • et al.
        Association between adiposity in midlife and older age and risk of diabetes in older adults.
        JAMA. 2010; 303: 2504-2512
        • Wei G.S.
        • Coady S.A.
        • Reis J.P.
        • Carnethon M.R.
        • Coresh J.
        • D'Agostino Sr, R.B.
        • et al.
        Duration and degree of weight gain and incident diabetes in younger versus middle-aged black and white adults: ARIC, CARDIA, and the framingham heart study.
        Diabet Care. 2015; 38: 2042-2049
        • McArdle M.A.
        • Finucane O.M.
        • Connaughton R.M.
        • McMorrow A.M.
        • Roche H.M.
        Mechanisms of obesity-induced inflammation and insulin resistance: insights into the emerging role of nutritional strategies.
        Front Endocrinol (Lausanne). 2013; 4: 52
        • Wajchenberg B.L.
        Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome.
        Endocr Rev. 2000; 21: 697-738
        • White M.F.
        IRS proteins and the common path to diabetes.
        Am J Physiol Endocrinol Metab. 2002; 283: E413-E422
        • Ye J.
        • Gimble J.M.
        Regulation of stem cell differentiation in adipose tissue by chronic inflammation.
        Clin Exp Pharmacol Physiol. 2011; 38: 872-878
        • Castro A.V.
        • Kolka C.M.
        • Kim S.P.
        • Bergman R.N.
        Obesity, insulin resistance and comorbidities? Mechanisms of association.
        Arq Bras Endocrinol Metabol. 2014; 58: 600-609
        • Chen Z.
        • Yu R.
        • Xiong Y.
        • Du F.
        • Zhu S.
        A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease.
        Lipids Health Dis. 2017; 16: 203
        • Ye J.
        Regulation of PPARgamma function by TNF-alpha.
        Biochem Biophys Res Commun. 2008; 374: 405-408
        • Lowell B.B.
        • Shulman G.I.
        Mitochondrial dysfunction and type 2 diabetes.
        Science. 2005; 307: 384-387
        • Samuel V.T.
        • Shulman G.I.
        Mechanisms for insulin resistance: common threads and missing links.
        Cell. 2012; 148: 852-871
        • Lotta L.A.
        • Wittemans L.B.L.
        • Zuber V.
        • Stewart I.D.
        • Sharp S.J.
        • Luan J.
        • et al.
        Association of genetic variants related to gluteofemoral vs abdominal fat distribution with type 2 diabetes, coronary disease, and cardiovascular risk factors.
        JAMA. 2018; 320: 2553-2563
        • Li N.
        • Fu J.
        • Koonen D.P.
        • Kuivenhoven J.A.
        • Snieder H.
        • Hofker M.H.
        Are hypertriglyceridemia and low HDL causal factors in the development of insulin resistance?.
        Atherosclerosis. 2014; 233: 130-138
        • Katsuki A.
        • Sumida Y.
        • Urakawa H.
        • Gabazza E.C.
        • Murashima S.
        • Maruyama N.
        • et al.
        Increased visceral fat and serum levels of triglyceride are associated with insulin resistance in Japanese metabolically obese, normal weight subjects with normal glucose tolerance.
        Diabet Care. 2003; 26: 2341-2344
        • von Eckardstein A.
        • Sibler R.A.
        Possible contributions of lipoproteins and cholesterol to the pathogenesis of diabetes mellitus type 2.
        Curr Opin Lipidol. 2011; 22: 26-32
        • Drew B.G.
        • Rye K.A.
        • Duffy S.J.
        • Barter P.
        • Kingwell B.A.
        The emerging role of HDL in glucose metabolism.
        Nat Rev Endocrinol. 2012; 8: 237-245
        • Steiner G.
        • Vranic M.
        Hyperinsulinemia and hypertriglyceridemia, a vicious cycle with atherogenic potential.
        Int J Obes. 1982; 6: 117-124
        • Mingrone G.
        • Henriksen F.L.
        • Greco A.V.
        • Krogh L.N.
        • Capristo E.
        • Gastaldelli A.
        • et al.
        Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency.
        Diabetes. 1999; 48: 1258-1263
        • Holzl B.
        • Iglseder B.
        • Sandhofer A.
        • Malaimare L.
        • Lang J.
        • Paulweber B.
        • et al.
        Insulin sensitivity is impaired in heterozygous carriers of lipoprotein lipase deficiency.
        Diabetologia. 2002; 45: 378-384
        • Petersen K.F.
        • Dufour S.
        • Hariri A.
        • Nelson-Williams C.
        • Foo J.N.
        • Zhang X.M.
        • et al.
        Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease.
        N Engl J Med. 2010; 362: 1082-1089
        • Robciuc M.R.
        • Maranghi M.
        • Lahikainen A.
        • Rader D.
        • Bensadoun A.
        • Oorni K.
        • et al.
        Angptl3 deficiency is associated with increased insulin sensitivity, lipoprotein lipase activity, and decreased serum free fatty acids.
        Arterioscler Thromb Vasc Biol. 2013; 33: 1706-1713
        • Pihlajamaki J.
        • Karjalainen L.
        • Karhapaa P.
        • Vauhkonen I.
        • Taskinen M.R.
        • Deeb S.S.
        • et al.
        G-250A substitution in promoter of hepatic lipase gene is associated with dyslipidemia and insulin resistance in healthy control subjects and in members of families with familial combined hyperlipidemia.
        Arterioscler Thromb Vasc Biol. 2000; 20: 1789-1795
        • Stefan N.
        • Schafer S.
        • Machicao F.
        • Machann J.
        • Schick F.
        • Claussen C.D.
        • et al.
        Liver fat and insulin resistance are independently associated with the -514C>T polymorphism of the hepatic lipase gene.
        J Clin Endocrinol Metab. 2005; 90: 4238-4243
        • Lopez-Rios L.
        • Perez-Jimenez P.
        • Martinez-Quintana E.
        • Rodriguez Gonzalez G.
        • Diaz-Chico B.N.
        • Novoa F.J.
        • et al.
        Association of Taq 1B CETP polymorphism with insulin and HOMA levels in the population of the Canary Islands.
        Nutr Metab Cardiovasc Dis. 2011; 21: 18-24
        • Turner R.
        • Stratton I.
        • Horton V.
        • Manley S.
        • Zimmet P.
        • Mackay I.R.
        • et al.
        UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK prospective diabetes study Group.
        Lancet. 1997; 350: 1288-1293
        • Radtke M.A.
        • Midthjell K.
        • Nilsen T.I.
        • Grill V.
        Heterogeneity of patients with latent autoimmune diabetes in adults: linkage to autoimmunity is apparent only in those with perceived need for insulin treatment: results from the Nord-Trondelag Health (HUNT) study.
        Diabet Care. 2009; 32: 245-250
        • Tuomi T.
        • Carlsson A.
        • Li H.
        • Isomaa B.
        • Miettinen A.
        • Nilsson A.
        • et al.
        Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.
        Diabet. 1999; 48: 150-157
        • Hawa M.I.
        • Buchan A.P.
        • Ola T.
        • Wun C.C.
        • DeMicco D.A.
        • Bao W.
        • et al.
        LADA and CARDS: a prospective study of clinical outcome in established adult-onset autoimmune diabetes.
        Diabet Care. 2014; 37: 1643-1649
        • Zhou Z.
        • Xiang Y.
        • Ji L.
        • Jia W.
        • Ning G.
        • Huang G.
        • et al.
        Frequency, immunogenetics, and clinical characteristics of latent autoimmune diabetes in China (LADA China study): a nationwide, multicenter, clinic-based cross-sectional study.
        Diabetes. 2013; 62: 543-550
        • Takeda H.
        • Kawasaki E.
        • Shimizu I.
        • Konoue E.
        • Fujiyama M.
        • Murao S.
        • et al.
        Clinical, autoimmune, and genetic characteristics of adult-onset diabetic patients with GAD autoantibodies in Japan (Ehime Study).
        Diabet Care. 2002; 25: 995-1001
        • Lee S.H.
        • Kwon H.S.
        • Yoo S.J.
        • Ahn Y.B.
        • Yoon K.H.
        • Cha B.Y.
        • et al.
        Identifying latent autoimmune diabetes in adults in Korea: the role of C-peptide and metabolic syndrome.
        Diabet Res Clin Pract. 2009; 83: e62-e65